Global Drug Discovery Market Growth, Trends, and Forecasts Report 2019-2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Drug
Discovery Market – Growth, Trends, and Forecast (2019 – 2024)”
report has been added to ResearchAndMarkets.com’s
offering.

The propelling factors for the growth of the drug discovery market
include the rising prevalence of a wide range of diseases (such as
cardiovascular and CNS-related disorders), rising healthcare
expenditure, and upcoming patent expiration of blockbuster drugs.

The diverse range of diseases, primarily cardiovascular disease,
infectious diseases, diabetes, and kidney-related complications, has a
high prevalence, globally. Thus, the increasing prevalence of a diverse
range of diseases among all age groups and its burden, globally, drives
the demand for drug discovery and its market.

There has been an upsurge in the usage of advanced technologies, such as
high throughput, bioinformatics and combinatorial chemistry for better
drug candidate identification. Drug discovery has evolved significantly
with emerging technologies, helping the process to become more refined,
accurate, and less time consuming. Due to automation, multi-detector
readers, imaging hardware and software, high-throughput screening is one
of the most widely used drug discovery technologies.

In recent years, there has been a rising demand for specialty medicines
that is expected to ultimately influence the small molecule drug
discovery market in a positive manner, as most of the specialty
medicines are small molecules.

The gradual rise in the healthcare expenditure regionally helps the new
pharmaceutical technology advancement. Although with high expenditure,
there is a need for redirecting the resources, the transition toward
better usability of healthcare expenditure for drug development is under
progress.

Scope of the Report

As per the scope of the report, drug discovery is a process, which aims
at identifying a compound therapeutically useful in treating and curing
diseases. Typically, a drug discovery effort addresses a biological
target that has been shown to play a role in the development of the
disease or starts from a molecule with interesting biological
activities. In the recent past, drug discovery has evolved significantly
with emerging technologies, helping the process to become more refined,
accurate, and less time consuming.

Key Market Trends

Biologics Drug is the Segment that is Expected to Grow Fastest under
Drug Type

A biologic drug is a product that is produced from living organisms or
contains components of living organisms. Biologic drugs include a wide
variety of products derived from human, animal, or microorganisms.
Biologic drugs are used for the treatment of numerous diseases and
conditions and are the most advanced therapies available. Biologic
treatments are for autoimmune diseases, which include the treatments for
rheumatoid arthritis, psoriasis, ulcerative colitis, Crohn’s disease,
and a range of related disorders, and have continued to see increasing
usage across geographies. The biologic drugs are expected to be fueled
by innovations in oncology, autoimmune, and diabetes treatments, with
particular important opportunities for biologics in the oncology and
autoimmune sectors.

The increasing applications of small molecule drugs for the treatment of
chronic diseases are leading to the increased demand for these drugs in
the market. Moreover, due to the aforementioned factors, small molecule
drugs dominate the biologics in the current healthcare market.

Asia-Pacific Holds the Fastest Growth and is Expected to Follow
the Same Trend Over the Forecast Period

The Asia Pacific is the fastest-growing region, due to the presence of
skilled labor at an affordable cost, the rise in disposable income, and
favorable government policies that are contributing to the market
growth. There has also been phenomenal growth in the outsourcing
companies in the Chinese region, over the last decade, which has
complemented the restructuring of the R&D that has taken place. Thus,
owing to the large deals of pharmaceutical companies and more number of
research being done, the market for drug discovery is expected to grow.

Competitive Landscape

The market studied has various pharmaceutical companies that are
investing billions of dollars in artificial intelligence (AI), in order
to make the drug discovery process significantly faster and cost
efficient. The pharmaceutical and biotech companies are increasing their
collaborations with contract development and manufacturing
organizations; thus, playing a crucial role in the development and
innovation of new drugs.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Market Dynamics

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of a Diverse Range of Diseases

4.2.2 Technological Advancements and Innovations

4.2.3 Increasing Healthcare Expenditure

4.2.4 Patent Expiration of Blockbuster Drugs

4.3 Market Restraints

4.3.1 Huge Capital Investment with Low-profit Margins

4.3.2 Stringent Government Regulations

4.4 Porter’s Five Forces Analysis

5 Market Segmentation

5.1 By Drug Type

5.1.1 Small Molecule Drug

5.1.2 Biologic Drug

5.2 By Technology

5.2.1 High Throughput Screening

5.2.2 Biochips

5.2.3 Bioinformatics

5.2.4 Pharmacogenomics and Pharmacogenetics

5.2.5 Combinatorial Chemistry

5.2.6 Nanotechnology

5.2.7 Spectroscopy

5.2.8 Metabolomics

5.2.9 Other Technologies

5.3 By Service

5.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Services

5.3.2 Pharmaceutical Services

5.3.3 Chemical Services

5.3.4 Biological Services

5.4 By End User

5.4.1 Research Institutes

5.4.2 Pharmaceutical Companies

5.4.3 Contract Research Organizations(CROs)

5.4.4 Other End Users

5.5 Geography

6 Competitive Landscape

6.1 Company Profiles

6.1.1 Pfizer Inc.

6.1.2 GlaxoSmithKline PLC

6.1.3 Merck & Co. Inc.

6.1.4 Agilent Technologies Inc.

6.1.5 Eli Lilly and Company

6.1.6 F. Hoffmann-La Roche Ltd

6.1.7 Bayer AG

6.1.8 Abbott

6.1.9 AstraZeneca PLC

6.1.10 Shimadzu Corp.

7 Market Opportunities and Future Trends

For more information about this report visit https://www.researchandmarkets.com/research/67lkv3/global_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Discovery